Duopharma Biotech Berhad announced that company successfully made a further Sukuk Wakalah issuance of MYR 29.0 million under the Sukuk Wakalah Programme. The Sukuk Wakalah have tenures of 7 and 10 years. The proceeds from the issuance of the Sukuk Wakalah under the Sukuk Wakalah Programme shall be utilised towards the following purposes, which shall be Shariah-compliant: 1. to repay/refinance the Issuer?s or its subsidiaries?

existing borrowings/Islamic financing and future Islamic financing, existing shareholder loans and existing inter-company loans and future Shariah-compliant inter-company advances; and/or 2. to finance future and present Shariah-compliant investments; and/or 3. to finance the Issuer Group?s Shariah-compliant working capital and capital expenditure requirements; and/or 4. to defray fees, expenses, costs and all other amounts payable in relation to the Sukuk Wakalah Programme.